about
Brazilin isolated from Caesalpinia sappan L. acts as a novel collagen receptor agonist in human plateletsPlatelet Activation: The Mechanisms and Potential BiomarkersPlatelet signalingPathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activationNext-generation antithrombotics in ischemic stroke: preclinical perspective on 'bleeding-free antithrombosis'Identification of platelet function defects by multi-parameter assessment of thrombus formationThe Nbeal2(-/-) mouse as a model for the gray platelet syndrome.Podocyte dysfunction in atypical haemolytic uraemic syndrome.Von Willebrand factor regulation in patients with acute and chronic cerebrovascular disease: a pilot, case-control study.Rare platelet GPCR variants: what can we learn?Case-control study of platelet glycoprotein receptor Ib and IIb/IIIa expression in patients with acute and chronic cerebrovascular disease.Platelets are relevant mediators of renal injury induced by primary endothelial lesionsExtracellular matrix proteins in hemostasis and thrombosisEDTA-treated cotton-thread microfluidic device used for one-step whole blood plasma separation and assay.Ambient fine particles (PM2.5 ) attenuate collagen-induced platelet activation through interference of the PLCγ2/Akt/GSK3β signaling pathway.Circulating primers enhance platelet function and induce resistance to antiplatelet therapy.Dynamic and structural formation of a thrombus: the inciting event of arterial ischemic strokeWiskott-Aldrich syndrome protein (WASp) controls the delivery of platelet transforming growth factor-β1Honokiol as a specific collagen receptor glycoprotein VI antagonist on human platelets: Functional ex vivo and in vivo studies.Regulating thrombus growth and stability to achieve an optimal response to injury.Platelet biology: the role of shear.The effects of arterial flow on platelet activation, thrombus growth, and stabilization.Harnessing the platelet signaling network to produce an optimal hemostatic response.Molecular biology of atherosclerosis.Proteomic profiling of platelet signalling.Novel synthetic benzimidazole-derived oligosaccharide, M3BIM, prevents ex vivo platelet aggregation and in vivo thromboembolismRAP1-GTPase signaling and platelet function.An interaction map of circulating metabolites, immune gene networks, and their genetic regulation.Model systems for platelet receptor shedding.Amplification of bacteria-induced platelet activation is triggered by FcγRIIA, integrin αIIbβ3, and platelet factor 4.Effects of preoperative aspirin on perioperative platelet activation and dysfunction in patients undergoing off-pump coronary artery bypass graft surgery: A prospective randomized study.A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies.The novel NOX inhibitor 2-acetylphenothiazine impairs collagen-dependent thrombus formation in a GPVI-dependent manner.CLEC-2: the inside story.Pathogen reduction treatment using riboflavin and ultraviolet light impairs platelet reactivity toward specific agonists in vitro.The anti-adhesive and anti-aggregatory effects of phenolics from Trifolium species in vitro.Comprehensive evaluation of haemostatic function in von Willebrand disease patients using a microchip-based flow chamber system.Gq pathway regulates proximal C-type lectin-like receptor-2 (CLEC-2) signaling in platelets.Microfluidic impedance cytometer for platelet analysis.Streptococcus sanguinis-induced cytokine release from platelets.
P2860
Q21284423-456E7511-6AE1-449E-A05F-52511EAE32A1Q26741080-17E46A48-2206-4C7A-A839-58F2D0B9A76DQ26824744-81294487-D885-43AF-A7DC-7C8D29BF8972Q26864770-1FD24ADF-77B9-4FF9-8829-F332437AA35AQ26865345-B8C67CBE-8250-4FA4-90AE-60BD0DF5FA0EQ28530023-EA28E672-EACB-4B75-A14A-9A5BC95AE391Q33416324-9CDA3020-E514-4853-8520-DBC001130E3FQ33419853-B51F9E38-6F37-495D-8E21-A90CB3598737Q33768997-25124532-599D-427D-9B21-A1A7D3515BD4Q34439244-C058594F-DD05-4D46-AC53-E3F98DCFA153Q35154663-449D7C49-9D0F-4214-8D73-2AB9DB6111C0Q35671848-27B3AACA-512A-4EC0-81B0-4C9445E77585Q35762807-7CD6B733-31B2-481D-B11F-FDEF52F5FDE3Q35972203-FEC58EA0-959A-470D-BDFC-52B882DDF507Q35979808-507D8DD2-5B1C-44AC-9FE5-B619AE0091A6Q36140286-9D15A018-4A83-470A-8FB0-B03C9094084DQ36907577-E9876D22-A081-47FB-9658-1596EE09779AQ37348866-B8E143C9-D52C-4997-9513-27027E8998D1Q37557842-15B625EE-9B64-4476-9B6E-526AF883DDE6Q37903932-C13E56BA-1CEA-4109-82AD-206D952BEAEEQ38095124-71D00E83-D07B-47E4-A101-BBA12A89808EQ38106013-6CEB0080-BB3E-430D-9121-54953D0511BCQ38109969-F2860839-538D-422B-9B4A-EAAAC80C2180Q38125279-E7EA112E-63F5-4239-BB53-B06AE61D31BAQ38132915-53776B81-7E74-438F-966A-F84E83C79FCEQ38525064-E1533D7C-647E-4632-9B7A-21360B160132Q38596028-E46818CA-8285-485A-BA4B-A708CF58FB79Q38648346-5E392601-4A55-460F-AA2D-DE73E9F8D731Q38874473-A95C643E-8B81-4013-AA1C-C8645D9FBB61Q39675280-66E3C582-1AD9-46CD-9D1B-F65EC6943996Q41034693-3FCDFCC5-74C9-4AAE-934A-8AAABBEC03F6Q41533935-EE9757FA-CA8D-4FB6-8899-19BC6B0FEF9EQ41819330-98DC1A5A-C780-40E7-AC39-4868CE2F9410Q41892042-B1095E9E-FD3C-4EF5-B093-B1E6D0F8E8EDQ42456722-1B962B44-B30F-44A9-9FD9-64DF114BB649Q43079765-A5ECCFC4-196A-4645-894E-B789BE2E99ADQ45871576-E50652AB-F8E4-4BCC-9085-EAAEFFCFB50AQ50892082-EF235E60-6D1F-4CBE-A21B-BF5559A5759CQ51534595-72C625E6-5717-4FEA-9F25-97CA61B5A0F9Q54569157-B47BEC19-E943-412F-9DE7-43E760E859A0
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Platelet receptor signaling in thrombus formation.
@en
Platelet receptor signaling in thrombus formation.
@nl
type
label
Platelet receptor signaling in thrombus formation.
@en
Platelet receptor signaling in thrombus formation.
@nl
prefLabel
Platelet receptor signaling in thrombus formation.
@en
Platelet receptor signaling in thrombus formation.
@nl
P2860
P1476
Platelet receptor signaling in thrombus formation.
@en
P2093
Bernhard Nieswandt
P2860
P2888
P304
P356
10.1007/S00109-010-0691-5
P577
2010-11-07T00:00:00Z